Who owns INTENSITY THERAPEUTICS INC?
- Ticker: INTS
- CUSIP Number: 45828j202
Tip: Access positions for across all investors
Analyze quarterly positions in Intensity Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Intensity Therapeutics stock
Who bought or sold INTENSITY THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Kmt Wealth Management | 497k | $2.0M | 100% | Jun 2026 |
|
| Geode Capital Management | 26k | $153k | 100% | Mar 2026 |
|
| Sapient Capital | 26k | $107k | 0% | Jun 2026 |
|
| Nano Cap New Millennium Growth Fund | 25k | $147k | 100% | Mar 2026 |
|
| Sentinus | 23k | $137k | 100% | Mar 2026 |
|
| FNY Investment Advisers | 22k | $90k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 17k | $99k | 100% | Mar 2026 |
|
| Mesirow Financial Investment Management International Equity | 14k | $58k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 9.1k | $54k | 100% | Mar 2026 |
|
| Goss Wealth Management | 1.1k | $6.8k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 200.00 | $1.2k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 200.00 | $1.2k | 100% | Mar 2026 |
|
| UBS Group | 192.00 | $1.1k | 100% | Mar 2026 |
|
| Tower Research Capital | 67.00 | $394.000200 | 100% | Mar 2026 |
|
| Morgan Stanley | 20.00 | $118.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 6.00 | $25.000200 | 100% | Jun 2026 |
|